Nectar Lifesciences Limited

NSE:NECLIFE.NS

44.08 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 198.06-203.507200.362-178.94175.8-142.712140.616-182.675177.75-164.354159.789-259.951255.01-2,073.672278.79-214.6212.56-1,882.445207.611-218.327212.89
Short Term Investments 4.948407.014134.389357.88420.733285.4241,676.497365.354.6328.7081,570.238519.9024.574,147.3441,794.882429.21.663,764.891,674.834436.6545.06
Cash and Short Term Investments 203.008203.507334.751178.94596.533142.7121,817.113182.675182.35164.3541,730.027259.951259.582,073.6722,073.672214.6214.221,882.4451,882.445218.327217.95
Net Receivables 3,801.17103,004.39902,799.80503,260.39406,721.703,956.75606,196.7803,693.71806,069.1204,921.85107,164.57
Inventory 7,091.51506,485.59506,726.00106,851.6606,598.5506,246.91905,878.8809,043.7709,775.5109,432.73609,179.7
Other Current Assets 1,742.63502,256.67602,189.4940835.698045.890909.565053.050421.48092.730762.6990128.08
Total Current Assets 12,838.329203.50712,081.421178.9412,311.833142.71212,764.865182.67513,548.49164.35412,843.267259.95112,388.292,073.67215,232.64214.616,151.581,882.44516,999.731218.32716,690.3
Non-Current Assets:
Property, Plant & Equipment, Net 6,560.61406,721.90406,904.28607,301.80707,651.7407,874.48808,321.5208,457.72308,606.5408,569.58408,851.88
Goodwill 000000000000000000000
Intangible Assets 523.9280507.6810493.2880461.4790430.210390.3750383.650344.4880391.910347.8960391.82
Goodwill and Intangible Assets 523.9280507.6810493.2880461.4790430.210390.3750383.650344.4880391.910347.8960391.82
Long Term Investments 112.3190-107.70202.3502.3510-1,610.8970-1,542.9430-2.220-1,767.58700.690-1,647.5390-2.36
Tax Assets 74.7780187.0470205.6880105.6590280150.52101,104.0802,017.07901,177.3401,722.92501,113.25
Other Non-Current Assets 1,800.595-203.5072,036.92-178.941,974.668-142.7122,247.506-182.6753,860.777-164.3543,965.975-259.9512,515.89-2,073.6721,063.337-214.65.02-1,882.4451,057.439-218.3274.99
Total Non-Current Assets 9,072.234-203.5079,345.85-178.949,580.28-142.71210,118.802-182.67510,359.83-164.35410,838.416-259.95112,322.92-2,073.67210,115.04-214.610,181.5-1,882.44510,050.305-218.32710,359.58
Total Assets 21,910.563021,427.271021,892.113022,883.667023,908.32023,681.683024,711.19025,347.68026,333.08027,050.036027,049.88
Liabilities & Equity:
Current Liabilities:
Account Payables 4,196.61203,404.73703,187.52303,627.3603,766.5203,500.50903,421.5303,754.30505,271.4505,441.55805,314.55
Short Term Debt 4,952.27604,979.78205,273.57305,319.34605,688.5104,856.74207,751.7206,613.44406,572.8206,572.84707,378.61
Tax Payables 0000000000000034.632036.050116.15090.07
Deferred Revenue 123.330337.5650362.3140159.5970120.63301,127.1280700.6801,180.7810634.6501,066.828090.07
Other Current Liabilities 455.9530123.245085.8630334.6070462.6670349.9670-0.010323.3430-0.010251.9050215.84
Total Current Liabilities 9,728.17108,845.32908,909.27309,440.91010,038.3309,834.346011,873.92011,871.873012,478.91013,333.138012,999.07
Non-Current Liabilities:
Long Term Debt 1,403.08701,832.92902,264.72102,576.94602,910.7503,101.90801,282.3701,220.35401,214.8201,226.73801,655.9
Deferred Revenue Non-Current 7.460007.710007.960008.210100.84708.460144.6208.71
Deferred Tax Liabilities Non-Current -7.46000-7.7100063.93000830.0501,039.75901,164.7801,136.62901,121.73
Other Non-Current Liabilities 86.827074.711072.1730172.04308.31088.541096.3508.3330104.8708.7080212.86
Total Non-Current Liabilities 1,489.91401,907.6402,336.89402,748.98902,990.9503,190.44902,216.9802,369.29302,492.9302,516.69502,999.2
Total Liabilities 11,218.085010,752.969011,246.167012,189.899013,029.28013,024.795014,090.9014,241.166014,971.84015,849.833015,998.27
Equity:
Preferred Stock 000000000000000000000
Common Stock 224.2610224.2610224.2610224.2610224.260224.2610224.260224.2610224.260224.2610224.26
Retained Earnings 7,039.210006,949.660007,191.480006,967.030007,707.980007,398.35
Accumulated Other Comprehensive Income/Loss 10,468.21710,674.30210,450.04110,645.95184.0410,693.76810,469.50710,879.051141.0210,656.88810,432.62710,620.2973,512.2411,106.51410,882.25311,361.25-6,200.0811,200.20310,975.94211,051.611-5,749.76
Other Total Stockholders Equity -7,039.210003,287.9850003,322.28000-83.240009,629.080009,178.76
Total Shareholders Equity 10,692.47810,674.30210,674.30210,645.9510,645.94610,693.76810,693.76810,879.05110,879.0410,656.88810,656.88810,620.29710,620.2911,106.51411,106.51411,361.2511,361.2411,200.20311,200.20311,051.61111,051.61
Total Equity 10,692.47810,674.30210,674.30210,645.9510,645.94610,693.76810,693.76810,879.05110,879.0410,656.88810,656.88810,620.29710,620.2911,106.51411,106.51411,361.2511,361.2411,200.20311,200.20311,051.61111,051.61
Total Liabilities & Shareholders Equity 21,910.56310,674.30221,427.27110,645.9521,892.11310,693.76822,883.66710,879.05123,908.3210,656.88823,681.68310,620.29724,711.1911,106.51425,347.6811,361.2526,333.0811,200.20327,050.03611,051.61127,049.88